Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2009

Mar 3, 2009

29831_dirs_2009-03-03_4feb2d07-0132-4cba-9dcd-995308d68294.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2009-02-26

Reporting Person: MACKAY MARTIN (Senior Vice President)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-02-26 Stock Appreciation Rights $12.70 A 195896 Acquired 2014-02-26 Common Stock (195896.00) Direct

Footnotes

F1: Amendment filed to correct the number of stock appreciation rights granted on February 26, 2009.

F2: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant